AFP and neoplasm: Patients with elevated serum α-fetoprotein (AFP > 200 ng/dL; 49.1 vs. 34.9%, P < 0.001), large tumor size (>5 cm, 50.1% vs. ≤5 cm, 32.1%, P < 0.001), tumors without encapsulation (57.1 vs. 44.6%, P < 0.001), poor differentiation of tumor cells (40.1 vs. 23.5%, P < 0.001), or advanced BCLC tumor stage (Ptrend < 0.001) had a higher incidence of MVI (Table 2).